Atara Biotherapeutics (ATRA) EBIT (QoQ) (2013 - 2026)
Atara Biotherapeutics (ATRA) EBIT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Atara Biotherapeutics | 143.49 Mn | 126.94 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.10% |
| Mar 31, 2026 | -31.45% |
| Dec 31, 2025 | 28.29% |
| Sep 30, 2025 | -211.79% |
| Jun 30, 2025 | -91.76% |
| Mar 31, 2025 | 417.97% |
| Dec 31, 2024 | 43.91% |
| Sep 30, 2024 | -19.34% |
| Jun 30, 2024 | 41.66% |
| Mar 31, 2024 | 47.89% |
| Dec 31, 2023 | 13.86% |
| Sep 30, 2023 | 2.52% |
| Jun 30, 2023 | 4.80% |
| Mar 31, 2023 | 0.69% |
| Dec 31, 2022 | 10.73% |
| Sep 30, 2022 | -163.36% |
| Jun 30, 2022 | 63.58% |
| Mar 31, 2022 | 5.55% |
| Dec 31, 2021 | -10.13% |
| Sep 30, 2021 | -0.96% |